Evidence map›Paper›PMID 42713572›Full record

ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2026

Knowledge about prostate cancer and screening among men attending Kibogora Level Two Teaching Hospital.

Kabutare Jean Marie Vianney, David C Ikwuka, Margaret I Fitch

Abstract read
In one paragraph

Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kabutare Jean Marie VianneySchool of Nursing and Midwifery, College of Medicine and Health Sciences, University of Rwanda, Head of Yove Health Center, Kabutarejmv79@gmail.com.
David C IkwukaCollege of Medicine & Health Sciences, University of Rwanda, d.c.ikwuka@ur.ac.rw, davidikwuka@gmail.com.
Margaret I FitchBloomberg Faculty of Nursing, University of Toronto, Canada, Marg.i.fitch@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Globally, prostate cancer ranks as one of the primary causes of cancer-related mortality for men. Prostate cancer death rates in sub-Saharan Africa are 2.7 times higher than the global norm. Delayed detection of the disease is one of the factors that contributes to this high mortality. Currently, little is known about how Rwandan men perceive, know about, and approach prostate cancer screening. Purpose: This study was designed to evaluate the level of awareness about prostate cancer and screening among men attending Kibogora Level Two Teaching in Rwanda. Methods: A cross-sectional survey was conducted with a convenience sample of male patients showing symptoms of urinary tract infections or prostate cancer. The survey included questions about demographic characteristics, and prostate cancer risks, signs and symptoms, and screening. Descriptive statistics were utilized to identify frequencies in responses. Results: A total of 164 men completed the survey. Most men were farmers (88.0%) with 67.1% having primary level education. About a third were between 41 and 50 yeas of age. Only 38.4% had heard of prostate cancer. Participants identified obesity (62.2%), smoking (58.5%), and exposure to agent orange (55.5%) most frequently as risk factors and 31.1% named difficulty urinating most frequently as a symptom of prostate cancer. Other symptoms mentioned were blood in the urine (20.7%) and erectile dysfunction (18.3%). Only five men indicated they had ever been screened for prostate cancer. Conclusion: The study revealed this sample of Rwandan men had a low level of awareness and knowledge about prostate cancer and very few had engaged in prostate cancer screening. The results support the need for public education about the disease and screening approaches.

Indexed as

knowledge of prostate cancerprostate cancerscreening for prostate cancer

Identifiers

PMID42713572
PMCPMC13553049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.